Net Profit Margin
since 2005
Calculation
Danaher Corp., net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net earnings1 | ÷ | Sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 16.33% | = | 100 | × | 3,899) | ÷ | 23,875) |
| Dec 31, 2023 | 19.94% | = | 100 | × | 4,764) | ÷ | 23,890) |
| Dec 31, 2022 | 22.91% | = | 100 | × | 7,209) | ÷ | 31,471) |
| Dec 31, 2021 | 21.84% | = | 100 | × | 6,433) | ÷ | 29,453) |
| Dec 31, 2020 | 16.36% | = | 100 | × | 3,646) | ÷ | 22,284) |
| Dec 31, 2019 | 16.80% | = | 100 | × | 3,008) | ÷ | 17,911) |
| Dec 31, 2018 | 13.33% | = | 100 | × | 2,651) | ÷ | 19,893) |
| Dec 31, 2017 | 13.60% | = | 100 | × | 2,492) | ÷ | 18,330) |
| Dec 31, 2016 | 15.13% | = | 100 | × | 2,554) | ÷ | 16,882) |
| Dec 31, 2015 | 16.33% | = | 100 | × | 3,357) | ÷ | 20,563) |
| Dec 31, 2014 | 13.05% | = | 100 | × | 2,598) | ÷ | 19,914) |
| Dec 31, 2013 | 14.10% | = | 100 | × | 2,695) | ÷ | 19,118) |
| Dec 31, 2012 | 13.10% | = | 100 | × | 2,392) | ÷ | 18,260) |
| Dec 31, 2011 | 13.50% | = | 100 | × | 2,172) | ÷ | 16,091) |
| Dec 31, 2010 | 13.58% | = | 100 | × | 1,793) | ÷ | 13,203) |
| Dec 31, 2009 | 10.30% | = | 100 | × | 1,152) | ÷ | 11,185) |
| Dec 31, 2008 | 10.38% | = | 100 | × | 1,318) | ÷ | 12,697) |
| Dec 31, 2007 | 12.42% | = | 100 | × | 1,370) | ÷ | 11,026) |
| Dec 31, 2006 | 11.69% | = | 100 | × | 1,122) | ÷ | 9,596) |
| Dec 31, 2005 | 11.24% | = | 100 | × | 898) | ÷ | 7,985) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
The data reveal notable fluctuations in the key financial metrics over the observed period.
- Net Earnings
- Net earnings generally increased from 898 million US dollars in 2005 to a peak of 7,209 million US dollars in 2021, showing strong growth. However, there are periods of decline, notably in 2009, 2014, 2016, and after 2021, where earnings dropped significantly to 3,899 million US dollars by 2024. The sharp increase until 2021 suggests robust profitability, but the subsequent decline may indicate challenges or changes in business conditions.
- Sales
- Sales exhibited an overall upward trajectory, rising from 7,985 million US dollars in 2005 to a high of 31,471 million US dollars in 2022. Some volatility is evident, such as decreases in 2009 and 2016, corresponding with broader economic or industry-specific impacts. Sales slightly declined after 2022, stabilizing around 23,875 million US dollars by 2024. This trend shows expansive revenue growth with some setback in the most recent years.
- Net Profit Margin
- The net profit margin fluctuated but generally showed an improving trend, starting at 11.24% in 2005 and reaching a maximum of 22.91% in 2022. Notable drops occurred around 2008-2009 and after 2022. Despite these fluctuations, the margin mostly remained above 10%, highlighting consistent operational profitability with periods of enhanced efficiency. The decline from the peak margin in recent years aligns with the reduction in net earnings, suggesting margin compression or rising costs.
In summary, the financial data indicate strong growth in both earnings and sales for the majority of the period, accompanied by improving profitability margins. However, the later years reflect a downward correction in profitability and net earnings despite relatively high sales levels, possibly pointing to increased operational pressures or market challenges.
Comparison to Competitors
Danaher Corp., net profit margin, long-term trends, comparison to competitors
| Danaher Corp. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 16.33% | 7.59% | 12.77% | -18.53% | 23.51% | 1.68% | 15.84% | 26.68% | 12.62% | 31.07% | 14.77% | -4.86% |
| Dec 31, 2023 | 19.94% | 8.95% | 24.96% | 17.83% | 15.36% | 21.03% | 41.28% | 0.61% | 3.56% | 30.14% | 13.99% | 36.68% |
| Dec 31, 2022 | 22.91% | 20.39% | 26.42% | 13.71% | 21.88% | 17.02% | 18.90% | 24.49% | 31.01% | 35.64% | 15.47% | 37.20% |
| Dec 31, 2021 | 21.84% | 20.54% | 24.25% | 15.08% | 19.71% | 23.05% | 22.26% | 26.79% | 26.76% | 50.25% | 19.70% | 30.92% |
| Dec 31, 2020 | 16.36% | 10.08% | 29.97% | -21.20% | 25.24% | 0.51% | 17.82% | 14.72% | 22.53% | 41.35% | 19.79% | 43.70% |
| Dec 31, 2019 | 16.80% | 23.69% | 35.32% | 13.15% | 37.27% | 24.35% | 18.42% | 21.01% | 31.45% | 26.91% | 14.47% | 28.27% |
| Dec 31, 2018 | 13.33% | 17.36% | 37.25% | 21.81% | 13.16% | 25.16% | 18.75% | 14.71% | 20.79% | 36.42% | 12.06% | 68.80% |
| Dec 31, 2017 | 13.60% | 18.82% | 9.08% | 4.85% | -0.89% | 18.03% | 1.70% | 5.97% | 40.55% | 20.41% | 10.64% | 10.59% |
| Dec 31, 2016 | 15.13% | 23.22% | 35.27% | 22.94% | 12.90% | 45.07% | 23.01% | 9.85% | 13.66% | 18.42% | 11.06% | -6.58% |
| Dec 31, 2015 | 16.33% | 22.50% | 33.13% | 9.45% | 12.07% | 56.32% | 21.99% | 11.25% | 14.25% | 15.50% | 11.64% | -53.89% |
| Dec 31, 2014 | 13.05% | 8.89% | 26.69% | 12.62% | 12.19% | 49.44% | 21.96% | 28.22% | 18.42% | 12.34% | 11.22% | -127.25% |
| Dec 31, 2013 | 14.10% | 21.97% | 27.93% | 15.64% | 20.27% | 28.46% | 19.40% | 10.00% | 42.65% | 20.16% | 9.73% | -36.72% |
| Dec 31, 2012 | 13.10% | 28.70% | 26.11% | 11.12% | 18.09% | 27.57% | 16.14% | 13.05% | 24.70% | 54.43% | 9.42% | -7.01% |
| Dec 31, 2011 | 13.50% | — | 24.08% | 17.46% | 17.90% | 34.60% | 14.87% | 13.05% | 14.84% | -49.74% | 11.34% | 2.10% |
| Dec 31, 2010 | 13.58% | — | 31.56% | 15.92% | 21.97% | 39.26% | 21.65% | 1.87% | 12.18% | -22.76% | 9.60% | -526.35% |
| Dec 31, 2009 | 10.30% | — | 32.09% | 56.42% | 19.82% | 40.74% | 19.82% | 47.04% | 17.27% | -17.88% | 8.41% | -630.27% |
| Dec 31, 2008 | 10.38% | — | 28.57% | 25.47% | -10.17% | 39.55% | 20.31% | 32.74% | 16.78% | -34.69% | 9.47% | -262.02% |
| Dec 31, 2007 | 12.42% | — | 22.12% | 11.19% | 15.85% | 43.27% | 17.31% | 13.54% | 16.82% | -84.46% | 7.81% | -196.61% |
| Dec 31, 2006 | 11.69% | — | 21.29% | 8.85% | 16.97% | -45.98% | 20.73% | 19.59% | 39.98% | -161.30% | 4.46% | -95.63% |
| Dec 31, 2005 | 11.24% | — | 30.56% | 15.62% | 13.52% | 44.99% | 20.61% | 21.04% | 15.76% | -144.19% | 8.48% | -126.43% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Danaher Corp., net profit margin, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Danaher Corp. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2024 | 16.33% | 12.30% |
| Dec 31, 2023 | 19.94% | 17.95% |
| Dec 31, 2022 | 22.91% | 22.55% |
| Dec 31, 2021 | 21.84% | 23.38% |
| Dec 31, 2020 | 16.36% | 14.07% |
| Dec 31, 2019 | 16.80% | 23.22% |
| Dec 31, 2018 | 13.33% | 19.82% |
| Dec 31, 2017 | 13.60% | 13.06% |
| Dec 31, 2016 | 15.13% | 20.78% |
| Dec 31, 2015 | 16.33% | 21.17% |
| Dec 31, 2014 | 13.05% | 21.24% |
| Dec 31, 2013 | 14.10% | 21.99% |
| Dec 31, 2012 | 13.10% | 18.53% |
| Dec 31, 2011 | 13.50% | 15.70% |
| Dec 31, 2010 | 13.58% | 15.16% |
| Dec 31, 2009 | 10.30% | 25.73% |
| Dec 31, 2008 | 10.38% | 18.17% |
| Dec 31, 2007 | 12.42% | 15.90% |
| Dec 31, 2006 | 11.69% | 22.24% |
| Dec 31, 2005 | 11.24% | 18.33% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Danaher Corp., net profit margin, long-term trends, comparison to industry (health care)
| Danaher Corp. | Health Care | |
|---|---|---|
| Dec 31, 2024 | 16.33% | 7.02% |
| Dec 31, 2023 | 19.94% | 9.24% |
| Dec 31, 2022 | 22.91% | 11.62% |
| Dec 31, 2021 | 21.84% | 12.42% |
| Dec 31, 2020 | 16.36% | 8.45% |
| Dec 31, 2019 | 16.80% | 11.58% |
| Dec 31, 2018 | 13.33% | 9.92% |
| Dec 31, 2017 | 13.60% | 8.05% |
| Dec 31, 2016 | 15.13% | 10.68% |
| Dec 31, 2015 | 16.33% | 11.77% |
| Dec 31, 2014 | 13.05% | 12.15% |
| Dec 31, 2013 | 14.10% | 12.81% |
| Dec 31, 2012 | 13.10% | 11.86% |
| Dec 31, 2011 | 13.50% | 10.50% |
| Dec 31, 2010 | 13.58% | 10.48% |
| Dec 31, 2009 | 10.30% | 15.08% |
| Dec 31, 2008 | 10.38% | 11.35% |
| Dec 31, 2007 | 12.42% | 11.02% |
| Dec 31, 2006 | 11.69% | 13.95% |
| Dec 31, 2005 | 11.24% | 13.38% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).